Telomir Pharmaceuticals (TELO) News Today → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free TELO Stock Alerts $6.86 +0.07 (+1.03%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineTelomir Pharmaceuticals (NASDAQ:TELO) Stock Price Down 2.4%americanbankingnews.com - April 26 at 3:04 AMmarketbeat.com - April 22 at 11:35 AMTelomir Pharmaceuticals Unveils Compelling Pre-clinical Data on Age-Reversal Drug Telomir-1 at National Press Club Event in Washington, D.C.globenewswire.com - April 16 at 8:30 AMTelomir Pharmaceuticals' Anti-Aging Expert and NYT Bestselling Author Michael F. Roizen, MD, to Present Promising Pre-Clinical Data for Age-Reversal Drug Telomir-1 at the National Press Club in Washington, DC, on April 15, 2024globenewswire.com - April 2 at 8:30 AMUPDATE – Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in Caninesglobenewswire.com - March 29 at 4:44 PMTelomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in Caninesglobenewswire.com - March 26 at 8:30 AMTelomir Pharmaceuticals Releases New Pre-Clinical Data for Telomir-1 to Be Presented at the Global Longevity Federation Conference in Las Vegas on March 26thglobenewswire.com - March 22 at 8:30 AMTelomir Pharmaceuticals Uses AI Testing Models to Show its Lead Product Candidate's Potential in DNA Age Reversal Scienceglobenewswire.com - March 14 at 8:30 AMTelomir Pharmaceuticals Presents Promising Pre-Clinical Data For Its Lead Development Product at Singapore Conferenceglobenewswire.com - March 7 at 8:30 AMTelomir Pharmaceuticals Presents Promising Pre-Clinical Data For Its Lead Development Product at Singapore Conferenceglobenewswire.com - March 7 at 8:30 AMMichael F. Roizen, MD to Increase Activities with Telomir Pharmaceuticals as Special Advisor on Age Reversalglobenewswire.com - March 5 at 8:30 AMmarketbeat.com - February 20 at 10:09 AMmarketbeat.com - February 14 at 3:31 PMmarketbeat.com - February 14 at 3:14 PMmarketbeat.com - February 14 at 2:28 PMmarketbeat.com - February 14 at 2:11 PMmarketbeat.com - February 14 at 1:53 PMmarketbeat.com - February 12 at 1:34 PMmarketbeat.com - February 9 at 11:14 AMmarketbeat.com - February 9 at 11:04 AMmarketbeat.com - February 9 at 10:51 AM Get Telomir Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TELO and its competitors with MarketBeat's FREE daily newsletter. Email Address A new way to collect income from stocks (Ad)Most people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. TELO Media Mentions By Week TELO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TELO News Sentiment▼0.000.33▲Average Medical News Sentiment TELO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TELO Articles This Week▼21▲TELO Articles Average Week Get Telomir Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TELO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Lifecore Biomedical News G1 Therapeutics News Generation Bio News Zevra Therapeutics News Rigel Pharmaceuticals News Organigram News Acrivon Therapeutics News Ovid Therapeutics News Atossa Therapeutics News Design Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TELO) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHas Jeff Bezos Found the Next Nvidia?InvestorPlaceThe only accurate crypto trading system I know …Weiss RatingsMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telomir Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
